The preventive effect of antineoplaston AS2-1 on HCC recurrence.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Oncology Report

• Publication date

  2003-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3892/OR.10.2.391PMID 12579278
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A novel strategy for remission induction and maintenance in cancer therapy.

  2002cited by this paper
• Irregular regeneration of hepatocytes and risk of hepatocellular carcinoma in chronic hepatitis and cirrhosis with hepatitis-C-virus infection.

  1998cited by this paper
• Quick response of advanced cancer to chemoradiation therapy with antineoplastons.

  1998cited by this paper
• Germ‐line mutations of the p16INK4(MTS1) gene occur in a subset of patients with hepatocellular carcinoma

  1997cited by this paper
• Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.

  1995cited by this paper
• Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein.

  1995cited by this paper
• p53-dependent apoptosis modulates the cytotoxicity of anticancer agents.

  1993cited by this paper
• The Inhibitory Effect of the Combination of Antineoplaston A‐10 Injection with a Small Dose of cis‐Diamminedichloroplatinum on Cell and Tumor Growth of Human Hepatocellular Carcinoma

  1992cited by this paper
• Phenylacetate: a novel nontoxic inducer of tumor cell differentiation.

  1992cited by this paper
• Inhibition of chick brain cholesterogenic enzymes by phenyl and phenolic derivatives of phenylalanine.

  1991cited by this paper
• Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma.

  1989cited by this paper
• Antineoplastons: biochemical defense against cancer.

  1976cited by this paper

• Causal associations of BAFF-R on IgD+ CD24- B cell immune cell trait with hepatocellular carcinoma and the mediating role of phenylacetylglutamate levels: a Mendelian randomization study

  2024cites this paper
• Demethylation effect of the antineoplaston AS2-1 on genes in colon cancer cells

  2013cites this paper
• Integrative Oncology for Clinicians and Cancer Patients

  2010cites this paper
• Involvement of protein kinase C β–extracellular signal‐regulating kinase1/2/p38 mitogen‐activated protein kinase–heat shock protein 27 activation in hepatocellular carcinoma cell motility and invasion

  2008cites this paper
• Antineoplaston induces G(1) arrest by PKCalpha and MAPK pathway in SKBR-3 breast cancer cells.

  2005cites this paper
• Effects of antineoplaston AS2-1 against post-operative lung metastasis in orthotopically implanted colon cancer in nude rat.

  2005cites this paper
• Phase II study of antineoplaston A10 and AS2-1 in children with recurrent and progressive multicentric glioma : a preliminary report.

  2004cites this paper
• The Present State of Antineoplaston Research (1)

  2004cites this paper
• Phase II Study of Antineoplaston A10 and AS2-1 in Children with Recurrent and Progressive Multicentric Glioma

  2004cites this paper